Make the most of the booming pharma industry in Korea


Co-organised with KPTA (the Korea Pharmaceutical Traders Association), CPhI Korea attracts 200 exhibitors and 5,000 attendees to Seoul, becoming the must-attend event for international pharma companies who want to establish themselves within the Korean market – dubbed the most innovative worldwide.


Co-located with Health Ingredients Korea, attendees not only have access to the entire pharma supply chain, but to this established health ingredients show too.


“I am very satisfied with the meetings I’ve had. I’ve received a yearly update on what’s going on, what’s new, which direction the industry is going and news on what kind of new technologies are currently being developed, really very good.”

Dr. Oleg Siarkevych, Farmak JSC (Ukraine)


Attracting a quality audience with its ‘strictly professionals’ policy, CPhI Korea’s buyers include big pharma companies in search of ingredients and finished products. Visitors come to source Korea’s innovative pharmaceutical health products, while taking advantage of the event’s conference programme. Organised in collaboration with the Korean Ministry of Health, the conference delves into Korea’s latest industry trends, topics, regulations and innovations, while the event’s Meet the Expert programme offers hands-on advice to help international companies successfully enter the Korean market.


“We really thought the Meet the Expert Program was a valuable addition to CPhI Korea. We found the expert we spoke with very knowledgeable and he was able to provide us with a lot of hands on information on the Korean regulatory landscape. The fact that this was a “one -on-one” session meant that we could raise all our points.”

Marieke Van Dalen, Global Regulatory Specialist, APIC - Active Pharmaceutical Ingredients Committee (Netherlands)


Do not wait and visit cphi.com/korea to get your ticket to CPhI Korea today!

Go to article: Home | Ingredients on demandGo to article: In this issueGo to article: Scandinavian HealthGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: Hapa Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The pharma industry briefingGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Scott Gottlieb: achievements of the outgoing FDA commissionerGo to article: CapsugelGo to article: AlpexGo to article: Can Pharmaoffer become the Amazon of pharma raw materials?Go to article: Molnar Company InsightGo to article: MolnarGo to article: Is growth factor protein the future of Parkinson’s treatment?Go to article: AEB Company Insight Go to article: AEB Go to article: CBD: the myth, the magic and the real deal drugsGo to article: Swiss WorldCargoGo to article: Moehs Iberica SLGo to article: Could a pregnancy protein hold promise for new drugs?Go to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Antimicrobial resistance: sewage samples reveal bad sanitation as a key driverGo to article: BEAGo to article: 3MGo to article: PfanstiehlGo to article: EventsGo to article: Richter HelmGo to article: Event: CPhl KoreaGo to article: TSS Company InsightGo to article: TSS ABGo to article: Next issueGo to article: Baxter